University of Edinburgh

Three independent studies have shown that an α-synuclein assay technology detected early Parkinson's with high levels of sensitivity and specificity.

The model aims to uncover stroke patients at high, medium, or low risk of cerebral amyloid angiopathy, which is linked to additional strokes or dementia.

A combined biomarker model was more sensitive and specific than a standard test in identifying patients with liver injury after overdosing on paracetamol.